Frederic D. Price
Fredric D. Price is an American business executive. He is a former CEO of the pharmaceutical companies BioMarin Pharmaceutical and Chiasma. Price is the founder and CEO of Fig Tree Books, an American publishing company of American Jewish literary fiction.
Career[edit]
Price was the Vice President of Pfizer between 1973 and 1986 and the Vice President of Finance and Administration and CFO of Regeneron between 1991 and 1994.[1]
He was the chief executive of BioMarin Pharmaceutical between February 2000 and August 2004,[2] through having worked with BioMarin's cofounder and previous CEO Grant Denison Jr. at Pfizer in New York City, where they were coworkers for 13 years.[2] He served as the chairman of Omrix Pharmaceuticals between 2004 and 2008 and chairman and CEO of Chiasma between 2008 and 2013.[1][3]
Price received an undergraduate degree from Dartmouth College and an MBA from the Wharton School of the University of Pennsylvania.[1]
Fig Tree Books[edit]
Price is the founder and CEO of Fig Tree Books, an American publishing company of American Jewish literary fiction.[4] The publishing company was inspired by Price's strong interest in Jewish literature.[5] Before founding Fig Tree Books, Price started two established reading groups that discuss talk about Jewish books and essays.[6]
The publisher's name comes from a letter written by George Washington in 1790 to the Hebrew Congregation in Newport, Rhode Island, in which Washington wrote:
May the children of the Stock of Abraham, who dwell in this land, continue to merit and enjoy the good will of the other Inhabitants; while every one shall sit in safety under his own vine and fig tree, and there shall be none to make him afraid.[5]
Fig Tree Books will begin releasing books in March 2015.[5] The publisher is seeking to publish "original high quality literary fiction", as well as classics.[4] The initial four books that it will publish are Prayers for the Living by Alan Cheuse, Compulsion by Meyer Levin, The Book of Stone by Jonathan Papernick, and Safekeeping by Jessamyn Hope.[5][7] Fig Tree intends ultimately to publish a dozen or so novels a year, in both print and digital form.[5]
References[edit]
- ↑ 1.0 1.1 1.2 "Celsus Therapeutics Strengthens Board of Directors With Addition of Pharma/Biotech Industry Veteran Fredric Price" (Press release). Celsus Therapeutics. 2013-04-30. Archived from the original on 2014-12-20. Retrieved 2014-12-20.
- ↑ 2.0 2.1 Welte, Jim (2014-08-14). "Marin drug firm's chief resigns". Marin Independent Journal. Archived from the original on 2014-12-20. Retrieved 2014-12-20.
- ↑ Weinreb, Gail (2012-07-23). "Drug delivery co Chiasma raises $38.5m". Globes. Archived from the original on 2014-12-20. Retrieved 2014-12-20.
- ↑ 4.0 4.1 Ivry, Sara (2014-06-11). "New Jewish Publishing House To Launch in 2015". Tablet. Archived from the original on 2014-12-20. Retrieved 2014-12-20.
- ↑ 5.0 5.1 5.2 5.3 5.4 Williams, Wilda (2014-09-23). "A New Year, a New Publisher: Fig Tree Books". Library Journal. Archived from the original on 2014-12-20. Retrieved 2014-12-20.
- ↑ McDonough, Yona Zeldis (2014-02-20). "Print is Dead". Lilith (magazine). Archived from the original on 2014-12-20. Retrieved 2014-12-20.
- ↑ Casavant, Hillary (2014-09-23). "Up-and-coming book publishers". The Writer. Archived from the original on 2014-12-20. Retrieved 2014-12-20.
This article "Frederic D. Price" is from Wikipedia. The list of its authors can be seen in its historical. Articles copied from Draft Namespace on Wikipedia could be seen on the Draft Namespace of Wikipedia and not main one.
